Sometimes the most important advances are not breakthroughs in biology, but breakthroughs in giving patients one more meaningful option.

To provide the information your oncologist is not telling you or doesn't have the time to!

Sometimes the most important advances are not breakthroughs in biology, but breakthroughs in giving patients one more meaningful option.

The BRAF Pathway to TIL Program transforms TIL therapy from a last-minute scramble into a proactive treatment strategy.

I wanted to begin this post with a brief update and a moment of gratitude. AdventHealth Orlando has now been activated as an Authorized TIL Treatment Center for Iovance’s lifileucel, also known as Amtagvi, for eligible patients with advanced melanoma. Reaching this milestone in roughly three months has been both meaningful and energizing, especially as …

When science stays the course, time becomes part of the treatment.

Emerging data from ESMO 2025 highlight encouraging activity of the oncolytic virus RP1 plus nivolumab across several advanced non‑melanoma skin cancers, especially in PD‑1 naive and refractory settings.

Six weeks into my journey at AdventHealth, I’ve been both energized and humbled by what I’ve encountered. From the size and scale of the hospital system to the innovation in cancer care and research, here are 12 things that have stood out to me in a big way: 1. AdventHealth Orlando Is Massive — and …

A year defined by intentional choices—strengthening clinical excellence, embracing innovation, and building the personal and financial stability needed to care well for patients, teams, and family.

Living with intention means honoring time, embracing presence, and returning to purpose with a full heart.

A firewall against relapse — adjuvant immunotherapy steps into the spotlight for resected Merkel cell carcinoma.

Protecting vision, preserving the person — the promise of ocular-sparing oncology.